Intervention Protocol

You have full text access to this OnlineOpen article

Betahistine for symptoms of vertigo

  1. Louisa Murdin1,2,*,
  2. Kiran Hussain1,
  3. Anne GM Schilder1

Editorial Group: Cochrane Ear, Nose and Throat Disorders Group

Published Online: 11 AUG 2013

DOI: 10.1002/14651858.CD010696

How to Cite

Murdin L, Hussain K, Schilder AGM. Betahistine for symptoms of vertigo (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD010696. DOI: 10.1002/14651858.CD010696.

Author Information

  1. 1

    Faculty of Brain Sciences, University College London, Ear Institute, London, UK

  2. 2

    Guy's and St Thomas' NHS Foundation Trust, ENT Department, London, UK

*Louisa Murdin, louisa.murdin@ucl.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 11 AUG 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

This review aims to assess the effect of betahistine compounds in patients with vertigo. We will examine its effect on the frequency and severity of acute attacks of vertigo and on progression or deterioration of symptoms, as well as adverse effects.